Why is Mankind Pharma falling/rising?

As of 23-Jul, Mankind Pharma Ltd's stock price is currently at Rs 2,629.40, reflecting a decrease of Rs 41.25 or 1.54%. Today's performance indicates that the stock has underperformed its sector by 2.05%, with an intraday low of Rs 2,580.70, marking a decline of 3.37%. While the stock has shown a positive return of 14.42% over the past month and 26.41% over the past year, it has a year-to-date decline of 8.60%. The stock's moving averages are higher than the 20, 50, 100, and 200-day averages but lower than the 5-day average, suggesting mixed signals. Additionally, there has been a notable drop in investor participation, with delivery volume decreasing by 24.56% compared to the 5-day average, which may indicate waning interest among investors.
In the broader market context, Mankind Pharma's short-term return of 0.22% over the past week slightly outpaces the Sensex's return of 0.11%. Despite the recent decline, the company demonstrates strong fundamentals, including a high return on equity of 17.22% and a low debt-to-EBITDA ratio of 0.69, which supports its ability to service debt effectively. Furthermore, the stock has a healthy long-term growth outlook, with operating profits growing at an annual rate of 23.44%. High institutional holdings at 24.58% suggest that knowledgeable investors are backing the company, which could provide some stability despite the current price drop.